<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Zimmermann, Petra</dc:creator>
  <dc:creator>Curtis, Nigel</dc:creator>
  <dc:date>2020-03-03</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Coronaviruses (CoVs) are a large family of enveloped, single-stranded, zoonotic RNA  viruses. Four CoVs commonly circulate among humans: HCoV2-229E, -HKU1, -NL63  and -OC43. However, CoVs can rapidly mutate and recombine leading to novel CoVs  that can spread from animals to humans. The novel CoVs severe acute respiratory  syndrome coronavirus (SARS-CoV) emerged in 2002 and Middle East respiratory  syndrome coronavirus (MERS-CoV) in 2012. The 2019 novel coronavirus (SARS- CoV-2) is currently causing a severe outbreak of disease (termed COVID-19) in China  and multiple other countries, threatening to cause a global pandemic. In humans,  CoVs mostly cause respiratory and gastrointestinal symptoms. Clinical manifestations  range from a common cold to more severe disease such as bronchitis, pneumonia,  severe acute respiratory distress syndrome, multi-organ failure and even death.  SARS-CoV, MERS-CoV and SARS-CoV-2 seem to less commonly affect children and  to cause fewer symptoms and less severe disease in this age group compared with  adults, and are associated with much lower case-fatality rates. Preliminary evidence  suggests children are just as likely as adults to become infected with SARS-CoV-2 but  are less likely to be symptomatic or develop severe symptoms. However, the  importance of children in transmitting the virus remains uncertain. Children more often  have gastrointestinal symptoms compared with adults. Most children with SARS-CoV  present with fever, but this is not the case for the other novel CoVs. Many children  affected by MERS-CoV are asymptomatic. The majority of children infected by novel  CoVs have a documented household contact, often showing symptoms before them.  In contrast, adults more often have a nosocomial exposure. In this review, we  summarize epidemiologic, clinical and diagnostic findings, as well as treatment and  prevention options for common circulating and novel CoVs infections in humans with a  focus on infections in children.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/unifr/documents/308779</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308779/files/zim_cic.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/INF.0000000000002660</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>The Pediatric Infectious Disease Journal. - 2020, vol. 39, no. 5, p. 355–368</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Coronavirus infections in children including covid-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
